My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

116.29 -2.89 (-2.42%)

Streaming Delayed Price Updated: 12:49 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

2 Strong Healthcare Stock Picks for Growth Investors ↗

Today 8:15 EST

If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space.

Via The Motley Fool

TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Stock for GARP Investors ↗

November 04, 2025

TransMedics Group (TMDX) is a GARP stock with strong revenue & EPS growth, reasonable valuation vs. peers, and a solid financial position.

Via Chartmill

TransMedics Group Inc (NASDAQ:TMDX) Passes Rigorous Growth Stock Screen ↗

October 30, 2025

Discover how TransMedics Group (TMDX) exemplifies a powerful growth investing strategy with explosive sales, earnings growth, and soaring profitability.

Via Chartmill

Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ ↗

October 30, 2025

TransMedics shares fell 9% in after-hours trading after its third-quarter results showed strong year-over-year growth but a sequential slowdown and margin pressure.

Via Stocktwits

TransMedics (TMDX) Q3 2025 Earnings Transcript ↗

October 29, 2025

TransMedics (TMDX) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

A Peek at TransMedics Gr's Future Earnings ↗

October 28, 2025

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗

October 29, 2025

TransMedics (TMDX) Q3 2025 results show a mixed picture: EPS of $0.66 beat estimates by 84.6%, but revenue of $143.82M slightly missed forecasts.

Via Chartmill

4 Stocks to Load Up on Before Earnings ↗

October 26, 2025

It might be worth buying these companies before the market notices they are undervalued.

Via The Motley Fool

This CME Group Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

October 23, 2025

Via Benzinga

Here's How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today ↗

October 13, 2025

Via Benzinga

Is TransMedics Group Inc Gaining or Losing Market Support? ↗

October 13, 2025

Via Benzinga

4 Analysts Have This To Say About TransMedics Group ↗

October 13, 2025

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX): A GARP Investment with Strong Growth and Fair Valuation ↗

October 10, 2025

TransMedics (TMDX) is a top GARP stock with explosive revenue & earnings growth, strong profitability, and a reasonable valuation relative to its industry peers.

Via Chartmill

2 Outstanding Healthcare Stocks to Buy and Hold for a Decade ↗

October 08, 2025

These stocks are crushing the market this year, and there is likely plenty of upside ahead.

Via The Motley Fool

If You Invested $100 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today ↗

September 25, 2025

TransMedics Group (NASDAQ: TMDX) has outperformed the market over the past 5 years by 37.76% on an annualized basis producing an average annual return of 52.39%. Currently, TransMedics Group has a...

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX) Emerges as a Top Affordable Growth Stock ↗

September 18, 2025

TransMedics (TMDX) is a top affordable growth stock with strong revenue & EPS growth, solid financial health, and a reasonable valuation in the organ transplant tech sector.

Via Chartmill

The Analyst Verdict: TransMedics Group In The Eyes Of 4 Experts ↗

September 16, 2025

Via Benzinga

If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today ↗

September 15, 2025

Via Benzinga

$100 Invested In TransMedics Group 5 Years Ago Would Be Worth This Much Today ↗

August 29, 2025

Via Benzinga

TransMedEDICS Group Inc (NASDAQ:TMDX): An Affordable Growth Candidate in Organ Transplant Technology ↗

August 28, 2025

TransMedics (TMDX) shows explosive revenue & EPS growth, trading at a reasonable valuation given its strong position in the organ transplant tech market.

Via Chartmill

A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts ↗

August 25, 2025

Via Benzinga

Spotlight on TransMedics Group: Analyzing the Surge in Options Activity ↗

August 11, 2025

Via Benzinga

RadNet Posts Better-Than-Expected Earnings, Joins Tegna, MeridianLink, Lithium Argentina And Other Big Stocks Moving Higher On Monday ↗

August 11, 2025

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

August 07, 2025

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX): A Prime Example of Affordable Growth Investing ↗

August 06, 2025

Affordable Growth investing balances strong revenue/earnings growth with fair pricing, as seen in TransMedics (TMDX), with high growth metrics, reasonable valuation, and stable finances.

Via Chartmill

What TransMedics Just Taught Me About Trusting The Algorithm ↗

August 01, 2025

Via Benzinga

Why TransMedics Stock Is Skyrocketing Today ↗

July 31, 2025

TransMedics continues to lock in its status as the leader in organ transplant technology.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 31, 2025

Via Benzinga

TransMedics (TMDX) Q2 Revenue Jumps 38% ↗

July 31, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.